$SCNI Cashflow Statement | Understand Stock

$SCNI

$0.53 +$0.00 (0.58%) Close

$SCNI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net loss
Depreciation of property, plant and equipment and right-of-use assets
Net financial expenses (income)
Capital gain
Increase (decrease) in liability with respect to loans from others
Share-based compensation
Total adjustments to profit and loss
Decrease (increase) in other receivables
Increase (decrease) in trade payables
Increase in short and long-term other payables
Changes in asset and liability items total
Interest paid
Total cash paid and received
Net cash used in operating activities
Purchase of property and equipment
Proceeds from sale of property and equipment
Decrease (increase) in other long-term assets
Net cash used in investing activities
Proceeds from issuance of shares and options, net of issuance costs
Payment of lease liabilities
Net cash provided by financing activities
Exchange differences on balances of cash and cash equivalents
Increase (decrease) in cash and cash equivalents
Balance of cash and cash equivalents at the beginning of the year
Balance of cash and cash equivalents at the end of the year
Right-of-use asset recognized with corresponding lease liability
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation of property, plant and equipment
Expense of in-process research and development
SEPA commitment fees
Financial (income) expense related to loan from others
Revaluation of warrants
Gain on troubled debt restructuring
Share-based compensation
Decrease (increase) in trade receivables
Decrease (increase) in other receivables
Changes in operating lease right-of-use assets
Increase (decrease) in trade payables
Changes in operating lease liabilities
Increase (decrease) in other payables
Net cash used in operating activities
Cash flows from investing activities:
Purchase of property, plant and equipment
Net cash used in investing activities
Cash flows from financing activities:
Proceed from issuance of warrants
Proceed from exercise of warrants, net
Proceeds from issuance of shares, net
Proceeds from issuance of ordinary shares for SEPA holders, net
Net cash provided by financing activities
Effect of exchange rate changes on cash, cash equivalents and restricted cash
Increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
Cash, cash equivalents and restricted cash at end of year
Supplementary disclosure of cash flows activities:
Interest
(2) Non-cash transactions:
Exercise of warrants liability to equity
Recognition of right-of-use assets and lease liabilities upon exercise of lease extension option
Reclassification of warrants liability to equity
Shares issued for SEPA financing agreement
Loan convert into preferred shares
Exercise of warrants liability into shares

Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents
Restricted cash

Comments